Clopidogrel

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• FDA Prescribing Information: Clopidogrel (Plavix) — P2Y12 antiplatelet; CYP2C19 Black Box prodrug activation; PPI interaction; DAPT stent thrombosis; no reversal agent; platelet transfusion; prasugrel/ticagrelor alternatives; FATCAT veterinary feline HCM trial (2023) REGULATORY · 2023
• ASPCA Animal Poison Control Center: Cardiac Drug Toxicosis in Pets — statin myopathy in cats; beta-blocker bradycardia dogs; CCB toxicity (amlodipine/diltiazem); ACE inhibitor renal effects; warfarin anticoagulant; furosemide; toxic dose thresholds (2023) VETERINARY · 2023
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• where to look DrugBank, as recorded by PubChem (Experimental Properties, CID 60606; where-to-look, not a source of this value) DATABASE · 2026
• EPA CompTox CTX API: predicted properties for DTXSID6022848 (Clopidogrel) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.